Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP652803.RAEnaUYmG9IzOFFYxK4o5OOGlZfUot649TvjCx501xw-U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP652803.RAEnaUYmG9IzOFFYxK4o5OOGlZfUot649TvjCx501xw-U130_assertion type Assertion NP652803.RAEnaUYmG9IzOFFYxK4o5OOGlZfUot649TvjCx501xw-U130_head.
- NP652803.RAEnaUYmG9IzOFFYxK4o5OOGlZfUot649TvjCx501xw-U130_assertion description "[KLK2/3-expressing CTCs are common in men with CRPC and bone metastases but are rare in patients with metastases diagnosed only in soft tissues and patients with localized cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP652803.RAEnaUYmG9IzOFFYxK4o5OOGlZfUot649TvjCx501xw-U130_provenance.
- NP652803.RAEnaUYmG9IzOFFYxK4o5OOGlZfUot649TvjCx501xw-U130_assertion evidence source_evidence_literature NP652803.RAEnaUYmG9IzOFFYxK4o5OOGlZfUot649TvjCx501xw-U130_provenance.
- NP652803.RAEnaUYmG9IzOFFYxK4o5OOGlZfUot649TvjCx501xw-U130_assertion SIO_000772 19233911 NP652803.RAEnaUYmG9IzOFFYxK4o5OOGlZfUot649TvjCx501xw-U130_provenance.
- NP652803.RAEnaUYmG9IzOFFYxK4o5OOGlZfUot649TvjCx501xw-U130_assertion wasDerivedFrom befree-20140225 NP652803.RAEnaUYmG9IzOFFYxK4o5OOGlZfUot649TvjCx501xw-U130_provenance.
- NP652803.RAEnaUYmG9IzOFFYxK4o5OOGlZfUot649TvjCx501xw-U130_assertion wasGeneratedBy ECO_0000203 NP652803.RAEnaUYmG9IzOFFYxK4o5OOGlZfUot649TvjCx501xw-U130_provenance.